STOCK TITAN

Bard Associates (MODD) files amendment showing 102,831 shares owned

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Modular Medical, Inc. ownership update: Bard Associates, Inc. reports beneficial ownership of 102,831 shares of Common Stock as of 05/13/2026. The filing states this represents 0.1% of the class, with 3,716 shares sole voting power and 99,115 shares subject to shared dispositive power.

Positive

  • None.

Negative

  • None.

Insights

Minor passive holder disclosure; no control signal.

Bard Associates, Inc. files an amended Schedule 13G/A reporting 102,831 shares (0.1%). The filing classifies the stake as under 5% and lists voting/dispositive powers, indicating passive investor status rather than an activist intent.

Timing: the amendment is dated 05/13/2026. Future filings could show material change if ownership grows above regulatory thresholds.

Beneficial ownership 102,831 shares Amount beneficially owned as reported
Percent of class 0.1% Percent of class as reported
Sole voting power 3,716 shares Sole power to vote as reported
Shared dispositive power 99,115 shares Shared power to dispose or direct disposition
Filing date / signature 05/13/2026 Amendment signed by Michael Demaray, President
Beneficially owned regulatory
"Amount beneficially owned: 102831"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Sole Voting Power regulatory
"Sole Voting Power 3,716.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
Shared Dispositive Power regulatory
"Shared Dispositive Power 99,115.00"
Schedule 13G/A regulatory
"form_type: SCHEDULE 13G/A"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does Bard Associates report in MODD?

Bard Associates reports beneficial ownership of 102,831 shares in Modular Medical, representing 0.1% of the class. The filing dated 05/13/2026 also discloses 3,716 shares with sole voting power and 99,115 shares with shared dispositive power.

Does this Schedule 13G/A indicate control of Modular Medical?

No: the filing states ownership is 0.1%, below 5%, which is consistent with passive investor reporting. It lists voting and dispositive allocations but does not assert control or activist intent in the disclosed items.

What do the voting and dispositive power numbers mean in the filing?

The filing shows 3,716 shares of sole voting and sole dispositive power, and 99,115 shares of shared dispositive power. These values allocate who can vote or direct sale decisions for the reported shares under SEC reporting rules.

When was the ownership amount reported and who signed the filing?

The amendment is dated 05/13/2026 and is signed by Michael Demaray, President. The filing lists Bard Associates, Inc. as the reporting person and provides its Chicago address in Item 2.





60785L306

(CUSIP Number)
05/13/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



Bard Associates, Inc.
Signature:Michael Demaray
Name/Title:President
Date:05/13/2026